Vesicular Stomatitis Virus (VSV)

Powerful, Robust & Flexible

VSV is a bullet shaped RNA virus that has been strategically engineered to selectively replicate in and destroy cancer cells. VSV has biologic features that make it a POWERFUL, ROBUST and FLEXIBLE Oncolytic platform.

Features of our VSV Platform

Oncolytic VSV technology is exclusively licensed by Vyriad.  VSV infects cattle in Central America.  VSV grows very rapidly in cancer cells but not in healthy normal cells, and the oncolytic VSVs that Vyriad is developing have been engineered to further increase their cancer specificity.  The VSV genome can be strategically engineered by Vyriad to increase its potency for specific treatment indications, and to allow us to track the spread of the virus in the body with imaging studies.  Because human exposures are rare, most cancer patients do not have immunity to VSV, making it universally applicable as an intravenous cancer therapy.

check

BOOSTS ANTI-CANCER IMMUNITY

check

LYTIC DESTRUCTION

check

RAPID REPLICATION

check

NO PRIOR IMMUNITY

check

READILY ENGINEERED